C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
12/2002
12/24/2002	US6498178 Inhibitors of IMPDH enzyme
12/24/2002	US6498172 Prostaglandin agonists and their use to treat bone disorders
12/24/2002	US6498168 Muscarinic antagonists
12/19/2002	WO2002100855A1 Method of mycophenolate mofetil preparation
12/19/2002	WO2002100854A1 Lactone formulations and method of use
12/19/2002	WO2002100849A2 Novel nitriles useful as reversible inhibitors of cysteine proteases
12/19/2002	WO2002100846A1 Compounds and methods for the treatment or prevention of flavivirus infections
12/19/2002	WO2002100845A1 Hv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
12/19/2002	WO2002100844A2 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
12/19/2002	WO2002100830A1 Pyrrolidine derivatives as factor xa inhibitors
12/19/2002	WO2002100824A1 A novel alkaloid derivative and a pharmaceutical composition containing the same
12/19/2002	WO2002100822A1 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
12/19/2002	WO2002100813A2 Modulators of peroxisome proliferator activated receptors
12/19/2002	WO2002100812A1 Carboxylic acid derivative and salt thereof
12/19/2002	WO2002100802A2 Fluorous triphase and other multiphase systems
12/19/2002	WO2002100437A2 Ophthalmic compositions comprising hyaluronic acid
12/19/2002	WO2002100410A1 Methods of treating alzheimer's disease
12/19/2002	WO2002100403A1 Modulators of peroxisome proliferator activated receptors (ppar)
12/19/2002	WO2002100392A1 Orally administered dosage forms of gaba analog prodrugs having reduced toxicity
12/19/2002	WO2002100347A2 Prodrugs of gaba analogs, compositions and uses thereof
12/19/2002	WO2002070541A3 Peptide deformylase inhibitors
12/19/2002	WO2002050082A3 Inhibitors of papilloma virus
12/19/2002	US20020193622 For use as additives in chemical amplification photolithography, photoresists
12/19/2002	US20020193614 Treatment of cardiovascular disorders
12/19/2002	US20020193613 Method and device for cooling a hot reactor gas, for example in the production of phthalic anhydride
12/19/2002	US20020193596 Inhibitors of protein isoprenyl transferases
12/19/2002	US20020193446 Compounds and methods for the inhibition of the expression of VCAM-1
12/19/2002	US20020193428 4-(2-diethylaminoethoxy)-3,5-dihalobenzoyl derivative as antiarrhythmia agent
12/19/2002	US20020193427 A prostanoic acid derivative as c-c chemokine synthesis inhibitor and useful for the treatment of circulatory diseases, inflammation, allergic and renal diseases
12/19/2002	US20020193410 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benzopyrans
12/19/2002	US20020193383 1-(N-phenylalkylaminoalkyl)piperazine derivatives substituted at position 2 of the phenyl ring
12/19/2002	US20020193354 7, 9-substituted tetracycline compounds
12/19/2002	US20020193347 Using an optically active N-substituted chiral derivative of norephedrine as ligand for enantioselective reduction of unsaturated compounds carrying functional groups by a hydrogen transfer method
12/19/2002	US20020189033 Substituted 2-aminoalkyl-1,4diaminobenzene compounds and oxidation dye precursor compositions containing same
12/19/2002	DE10128818A1 Ascorbic acid and bioquinone are used in combination in angiogenetically-effective cosmetic and dermatological topical preparations e.g. for treatment of skin or hair
12/19/2002	DE10127126A1 New protected O-(2-substituted ethyl)-L-tyrosine derivatives, useful as intermediates for the positron emission tomography contrast agent O-(2-(18F)-fluoroethyl)-L-tyrosine
12/19/2002	DE10121003A1 Anthranilsäureamide, Verfahren zur Herstellung, ihrer Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen Anthranilic acid amides, processes for preparing, their use as a medicament as well as pharmaceutical compositions containing them
12/19/2002	CA2450269A1 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
12/19/2002	CA2450265A1 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
12/19/2002	CA2450013A1 Method of mycophenolate mofetil preparation
12/19/2002	CA2449948A1 Methods of treating alzheimer's disease
12/19/2002	CA2449673A1 Orally administered dosage forms of gaba analog prodrugs having reduced toxicity
12/19/2002	CA2449629A1 Pyrrolidine derivatives as factor xa inhibitors
12/19/2002	CA2449256A1 Modulators of peroxisome proliferator activated receptors
12/19/2002	CA2449213A1 Ophthalmic compositions comprising hyaluronic acid
12/19/2002	CA2448552A1 Modulators of peroxisome proliferator activated receptors (ppar)
12/19/2002	CA2445653A1 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
12/18/2002	EP1265883A1 Method for the preparation of citalopram
12/18/2002	EP1265882A1 Method for the preparation of citalopram
12/18/2002	EP1265881A1 Stepwise alkylation of 5-substituted 1-(4-fluorophenyl)-1,3-dihydroisobenzofurans
12/18/2002	EP1265880A1 Method for the preparation of citalopram
12/18/2002	EP1265879A1 Allomorph isomer z hydrochloride of ranitidine
12/18/2002	EP1265865A2 Difluorobutyric acid derivatives and their use as metalloprotease inhibitors
12/18/2002	EP1265862A2 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
12/18/2002	EP1265853A1 Carboxylic acid derivatives as ip antagonists
12/18/2002	EP1265849A2 Compounds and methods to treat alzheimer's disease
12/18/2002	EP1265839A1 Compounds active at the glucocorticoid receptor
12/18/2002	EP1265606A1 Cell adhesion inhibitors
12/18/2002	EP0869949B1 Benzoxazine antimicrobial agents
12/18/2002	CN1385427A Halogen contained aromatic compound
12/18/2002	CN1096454C Process for preparing benzofuranone derivatives
12/18/2002	CN1096446C N-(ortho-substd-benzyloxy)imine derivs, and their use as fungicides, acaricides or insecticides
12/17/2002	US6495719 Histone deacetylase inhibitors
12/17/2002	US6495699 Antiarthritic agents; osteoporosis
12/17/2002	US6495607 Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agents
12/17/2002	US6495370 A method for detecting a glutathione-s-transferase isoenzyme in a biological specimen comprising the measurement of glutathione-s-transferase enzymatic activity in the presence and absence an amount of a compound of the formula halo
12/17/2002	US6494503 Pipe joint assembly and method for using same
12/17/2002	CA2064783C Cytoprotective fatty moiety compounds
12/12/2002	WO2002098856A2 Piperazine oxyquinoline (naphthaline) platelet adenosine diphosphate receptor antagonists
12/12/2002	WO2002098851A1 Derivatives 0f n,s-substitutions n'-1 [(hetero)aryl] alkyl-n'-[hetero) aryl] methyl isothioureas, method for producing salts and bases thereof, physiologically active n,s-substitutions n'-1 [(hetero)aryl] alkyl-n'-[hetero) aryl] methyl isothioureas, a pharmaceutical composition and curing method
12/12/2002	WO2002098850A2 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors
12/12/2002	WO2002098849A2 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer’s disease and similar diseases
12/12/2002	WO2002098848A1 Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents
12/12/2002	WO2002098845A1 Compounds and methods for preparing methanesulfonamides
12/12/2002	WO2002098840A1 Carboxylic acid derivative and medicine comprising salt or ester of the same
12/12/2002	WO2002098830A1 A method for isolating phenolic substances or juvabiones from wood comprising knotwood
12/12/2002	WO2002098420A1 4-substituted-1-(arylmethylidene)thiosemicarbazide, 4-substituted-1-(arylcarbonyl)thiosemicarbazide and analogs as activators of caspases and inducers of apoptosis and the use thereof
12/12/2002	WO2002098406A1 Novel compounds and compositions as cathepsin inhibitors
12/12/2002	WO2002098363A2 NON-PEPTIDE GnRH AGENTS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR USES, AND PROCESSES FOR PREPARING THEM
12/12/2002	WO2002081398A3 Additives for building industry obtained from by-products and process for their production
12/12/2002	WO2002072548A3 Heterocyclic compounds and their use as histamine h4 ligands.
12/12/2002	WO2002057252A3 Heterocyclic sulfonamide inhibitors of beta amyloid production
12/12/2002	WO2001078720A8 Decreasing the intracellular level of beta-catenin by administering hydroxymatairesinol
12/12/2002	US20020188140 Purification method for obtaining high-purity pmda
12/12/2002	US20020188136 Pesticides and herbicides
12/12/2002	US20020188124 Novel spiro compounds
12/12/2002	US20020188120 Such as 4-(4-methyoxy-benzenesulfonyl)-1-(3-phenyl-propyl)-piperidine-4-carboxylic acid hydroxyamide for treatment of arthritis, tumor metastasis, tissue ulceration, abnormal wound healing, periodontal disease, bone diseases, diabetes, and HIV
12/12/2002	US20020188118 Compounds and methods for the inhibition of the expression of VCAM-1
12/12/2002	US20020187976 New benzofurane derivatives, their preparation process, their use as medicaments and the pharmaceutical compositions containing them
12/12/2002	CA2449843A1 Non-peptide gnrh agents, pharmaceutical compositions and methods for their use, and processes for preparing them
12/12/2002	CA2449021A1 Novel compounds and compositions as cathepsin inhibitors
12/12/2002	CA2448834A1 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases
12/12/2002	CA2448418A1 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors
12/12/2002	CA2446719A1 Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents
12/11/2002	EP1263860A1 New 3-arylbenzofuranones with electron-withdrawing substituents as stabilizers
12/11/2002	EP1263763A2 Tubulin binding ligands and corresponding prodrug constructs
12/11/2002	EP1263755A2 Cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
12/11/2002	EP1263750A1 Method for the preparation of citalopram
12/11/2002	EP1263743A1 Heterocycle substituted diphenyl leukotriene antagonists
12/11/2002	EP1263735A1 Acid addition salts of imidazolidinones as reaction catalysts

1 ... 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 ... 472